Category: Articles

Spirituality may be thought of as that which gives meaning and a feeling of vitality to one’s life. When people connect with their spirituality, they

Symptoms – Genetics – Treatments – Home Care – Emotional& psychological support – Activities of the IMSS Invited Guests: Rabbis and medical counselors Date: 05.07.2018,

SUMMARY c A study of more than 2,000 people with MS in Sweden suggests that people who had occupational exposure to organic solvents and certain

The U.S. Food and Drug Administration has approved the expansion of the use of the oral MS therapy Gilenya® (fingolimod, Novartis AG) to include the

The Israel Multiple Sclerosis Society and the MS Clinic at the Rambam Health Care Campus are happy to invite you to the: Conference for MS

The National Insurance Institute has issued for the first time a circular and form for the medical committees including of the deficiencies of which multiple

International MS Day will be remembered this year as a turning point in the National Insurance Institute’s approach to MS patients, with the publication of

My name is Dov Guggenheim. I’m a 20 year old yeshiva student who loves to learn. I take an interest in nearly everything, assuming it

Seven principles to improve quality of life with MS based on the insights and experience of people affected by MS and the organisations and professions

SUMMARY A team investigated health records and identified 2,312 people diagnosed with MS in two Canadian provinces. Over an average of more than 10 years,

Group for caregiving partners Parents group and parallel group of children with Multiple Sclerosis (dog training workshop) The workshop approach was formulated after drawing conclusions

this unique workshop was held for the first time following the diagnosis of very youngpatients with Multiple Sclerosis. During the workshops for their parents, the

Children’s Workshop: Dogs for companionship and assistance to children  (This workshop will be held in parallel to the parents’ workshop – on the same dates

Dear parents, we at the Israel Multiple Sclerosis Society, are currently organizing special workshops designed for you – parents and children. Over time, the Society

Researchers and health professionals gather for the latest updates and research findings on treatment, care and management of MS MS researchers from around the globe

The Israeli MS Society organises annual summer camps for people aged 6 to 18 who have a parent with MS. Every year 150-170 children participate

The American basketball player Chris Wright, who suffers from multiple sclerosis, has become a member of the Israel Multiple Sclerosis Society. Over the last few

(These problems have been recorded in the patients’ own words – we have not edited them) The Ministry of Health Mobility – The list of

says Executive Director of The Israel Multiple Sclerosis Society, Jeanine Weisberg At the Society’s request, a special discussion will be held tomorrow in the Labor,

Background: Maintaining cognitive function in multiple sclerosis is a major concern. It is a priority to identify factors that can help preserve cognition, in addition

Background: Patients with clinically isolated syndrome (CIS) who had early treatment with interferon beta-1b in the BENEFIT trial had significantly better clinical outcomes up to

Multiple Sclerosis affects over 2 million people, most of them young, from all over the globe. It may cause accumulative physical, cognitive and emotional disabilities

The results from a phase III clinical trial of Ocrelizumab in primary progressive MS are announced at ECTRIMS There are currently no approved disease-modifying therapies

Objective: Determine molecular effect of Vitamin D3 on interferon-beta response in mononuclear cells. Background: Oral vitamin D has additive effects on IFN-b therapy in reducing

Introduction: The BENEFIT trial demonstrated improved clinical outcomes in patients with a clinically-isolated syndrome (CIS) and early treatment with interferon beta-1b up to 11 years

Data from single-arm extension of head-to-head TRANSFORMS study show sustained reduction in relapses and rate of brain volume loss in patients on continuous Gilenya treatment

In honor of families, parents and children living with multiple sclerosis, and in order to encourage broader public awareness and understanding, the Israel Multiple Sclerosis

Results of a large randomized trial have shown that the combination interferon beta-1a and Gatiramer Acetate was not more effective than either agent alone on

Abstract: Enhancing quality of life (QoL) is an important objective of disease-modifying therapies in multiple sclerosis (MS). Strategies to substantiate the effect on QoL and